In this episode of AbbottTalks, Sandra Lesenfants, SVP of Abbott’s structural heart business, discusses the latest advancements in structural heart care, focusing on Abbott's transformative TriClip device for tricuspid regurgitation.

Lesenfants highlights Abbott’s commitment to patient-centered innovation, emphasizing the importance of creating solutions that meet patients’ needs through safe and effective technologies. She also shares Abbott’s approach to expanding access to minimally invasive therapies, particularly in underserved populations worldwide, and the role of physician partnerships in advancing structural heart interventions.

Lastly, Lesenfants underscores the company’s efforts to increase diversity in clinical trials, noting the importance of intentional inclusivity across gender and ethnicity to better serve diverse patient populations.

Thank you to Confluent Medical Technologies for sponsoring this episode of AbbottTalks. For more information on how Confluent Medical works with medical device companies, visit https://confluentmedical.com/.

Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

Abbott’s Lesenfants shares TriClip progress, patient-centered innovation & clinical trial diversity

INNOVATION & FINANCE: Is the traditional road show dead? Leslie Trigg, CEO of Outset Medical, fresh off taking the renal care company public, says despite initially grieving her inability to meet investors in person, she agrees that Zoom meetings gave her all the insights she needed to stage a successful IPO. In fact, she says the video calls might have even engendered a deeper understanding between executives and investors. Trigg also explains how Outset came to broaden its overall mission to create an enterprise system for dialysis. 

NEW TOOLS & TECHNOLOGY: The doctor will see you now … from 3,000 miles away. Doug Teany, COO of Corindus Vascular Robotics, says the company’s Corpath interventional robotic system will save lives and money by shortening the distance between critical patients and capable care. Using the emerging 5G network, Corindus is moving toward a future where interventionalists can treat patients in different area codes, time zones and countries. The company is profiled in a 5G documentary called “Speed of Thought.” Check it out on Amazon Prime and other channels.

Finally, the week wouldn't be complete with Chris Newmarker, executive editor of MassDevice, revealing this week’s #Newmarkersnewsmakers featuring news from Hologic, Varian, Smith & Nephew, and Outset Medical.

Outset CEO Leslie Trigg discusses Zoom-powered $278m IPO; Corindus COO Doug Teany sees  5G future

The DeviceTalks Podcast Network delivers news, insights and commentary from MedTech industry leaders, primarily from the largest OEMs in healthcare. Our podcasts will inspire MedTech professionals to create better MedTech devices and companies.

Explore the DeviceTalks Podcast Network, home to more than 11 podcasts:

• DeviceTalks Weekly
• AbbottTalks
• Boston Scientific Talks
• DeviceTalks AI
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Neuro Innovation Talks: J&J MedTech Neuro
• Structural Heart Talks: Edwards Lifesciences
• Ortho Innovation Talks: Zimmer Biomet
• StrykerTalks

WATCH our video podcasts on www.youtube.com/@DeviceTalks

Connect with the hosts:
Tom Salemi, Editorial Director, DeviceTalks https://www.linkedin.com/in/tom-salemi-7118948/
Kayleen Brown, Managing Editor, DeviceTalks https://www.linkedin.com/in/kayleenbrown/

Learn more about DeviceTalks - Podcasts • Conferences • Webinars - www.devicetalks.com